A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification

Free Radical Biology and Medicine

Volumn 63, Issue , 2013, Pages 369-380

  Iverson, Sonya V ^a   Eriksson, Sofi ^b   Xu, Jianqiang ^b   Prigge, Justin R ^a   Talago, Emily A ^a   Meade, Tesia A ^a   Meade, Erin S ^a   Capecchi, Mario R ^c   Arnér, Elias S J ^b   Schmidt, Edward E ^a,d  

^a MONTANA STATE UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF UTAH   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Bioenergetics; Drug metabolism; Redox biology; Thioredoxin reductase

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLYCOGEN; N ACETYL 1,4 BENZOQUINONE IMINE; PARACETAMOL; THIOREDOXIN REDUCTASE 1; URIDINE DIPHOSPHATE GLUCURONIC ACID; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOENERGY; BIOSYNTHESIS; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; DRUG METABOLISM; GENE EXPRESSION; GENE REPRESSION; GLUCURONIDATION; LIPOGENESIS; LIVER CELL; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84879469232     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.05.028     Document Type: Article

References (53)

1. Arnér, E. S. J.; Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267: 6102-6109; 2000.
2. Berndt, C.; Lillig, C. H.; Holmgren, A. Thiol-based mechanisms of the thior-edoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol 292:H1227-H1236; 2007. (Pubitemid 46377107)
3. Suvorova, E. S.; Lucas, O.; Weisend, C. M.; Rollins, M. F.; Merrill, G. F.; Capecchi, M. R.; Schmidt, E. E. Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes. PLoS One 4:e6158; 2009.
4. Locy, M. L.; Rogers, L. K.; Prigge, J. R.; Schmidt, E. E.; Arner, E. S.; Tipple, T. E. Thioredoxin reductase inhibition elicits Nrf2-mediated responses in Clara cells: implications for oxidant-induced lung injury. Antioxid. Redox Signal. 17 : 1407-1416; 2012.
5. Mandal, P. K.; Schneider, M.; Kolle, P.; Kuhlencordt, P.; Forster, H.; Beck, H.; Bornkamm, G. W.; Conrad, M. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res. 70: 9505-9514; 2010.
6. Arnér, E. S. J. Focus on mammalian thioredoxin reductases - important selenoproteins with versatile functions. Biochim. Biophys. Acta 1790: 495-526; 2009.
7. Chutkow, W. A.; Lee, R. T. Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability. J. Biol. Chem. 286: 29139-29145; 2011.
8. Andres, A. M.; Ratliff, E. P.; Sachithanantham, S.; Hui, S. T. Diminished AMPK signaling response to fasting in thioredoxin-interacting protein knockout mice. FEBS Lett. 585: 1223-1230; 2011.
9. Chutkow, W. A.; Birkenfeld, A. L.; Brown, J. D.; Lee, H. Y.; Frederick, D. W.; Yoshioka, J.; Patwari, P.; Kursawe, R.; Cushman, S. W.; Plutzky, J.; Shulman, G. I.; Samuel, V. T.; Lee, R. T. Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes 59: 1424-1434; 2010.
10. Chen, J. L.; Merl, D.; Peterson, C. W.; Wu, J.; Liu, P. Y.; Yin, H.; Muoio, D. M.; Ayer, D. E.; West, M.; Chi, J. T. Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA. PLoS Genet. 6; 2010.
11. Yu, F. X.; Chai, T. F.; He, H.; Hagen, T.; Luo, Y. Thioredoxin- interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glyco-lytic rate. J. Biol. Chem. 285: 25822-25830; 2010.
12. Parikh, H.; Carlsson, E.; Chutkow, W. A.; Johansson, L. E.; Storgaard, H.; Poulsen, P.; Saxena, R.; Ladd, C.; Schulze, P. C.; Mazzini, M. J.; Jensen, C. B.; Krook, A.; Bjornholm, M.; Tornqvist, H.; Zierath, J. R.; Ridderstrale, M.; Altshuler, D.; Lee, R. T.; Vaag, A.; Groop, L. C.; Mootha, V. K. TXNIP regulates peripheral glucose metabolism in humans. PLoS Med. 4:e158; 2007.
13. Kensler, T. W.; Wakabayashi, N.; Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47: 89-116; 2007.
14. Kobayashi, A.; Ohta, T.; Yamamoto, M. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol 378: 273-286; 2004.
15. Nguyen, T.; Nioi, P.; Pickett, C. B. The nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284: 13291-13295; 2009.
16. Nioi, P.; McMahon, M.; Itoh, K.; Yamamoto, M.; Hayes, J. D. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD (P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem. J 374: 337-348; 2003. (Pubitemid 37094093)
17. Aleksunes, L. M.; Manautou, J. E. Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol. Pathol. 35: 459-473; 2007. (Pubitemid 46911886)
18. Klaassen, C. D.; Slitt, A. L. Regulation of hepatic transporters by xenobiotic receptors. Curr. Drug Metab. 6: 309-328; 2005. (Pubitemid 41086765)
19. Okawa, H.; Motohashi, H.; Kobayashi, A.; Aburatani, H.; Kensler, T. W.; Yamamoto, M. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 339: 79-88; 2006. (Pubitemid 41697517)
20. Ni, H. M.; Boggess, N.; McGill, M. R.; Lebofsky, M.; Borude, P.; Apte, U.; Jaeschke, H.; Ding, W. X. Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol. Sci. 127: 438-450; 2012.
21. Hinson, J. A.; Roberts, D. W.; James, L. P. Mechanisms of acetaminophen-induced liver necrosis. Handb. Exp. Pharmacol : 369-405; 2010.
22. Zamek-Gliszczynski, M. J.; Hoffmaster, K. A.; Nezasa, K.; Tallman, M. N.; Brouwer, K. L. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. Eur. J. Pharm. Sci. 27: 447-486; 2006. (Pubitemid 43363339)
23. Homolya, L.; Varadi, A.; Sarkadi, B. Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate. Biofactors 17 : 103-114; 2003. (Pubitemid 37267146)
24. Thurman, R. G.; Kauffman, F. C. Sublobular compartmentation of pharmaco-logic events (SCOPE): metabolic fluxes in periportal and pericentral regions of the liver lobule. Hepatology 5: 14 4-151; 1985. (Pubitemid 15167058)
25. Price, V. F.; Schulte, J. M.; Spaethe, S. M.; Jollow, D. J. Mechanism of fasting-induced suppression of acetaminophen glucuronidation in the rat. Adv. Exp. Med. Biol. 197: 697-706; 1986.
26. Gillette, J. R.; Nelson, S. D.; Mulder, G. J.; Jollow, D. J.; Mitchell, J. R.; Pohl, L. R.; Hinson, J. A. Formation of chemically reactive metabolites of phenacetin and acetaminophen. Adv. Exp. Med. Biol. 136(Pt B): 931-950; 1981.
27. Miners, J. O.; Drew, R.; Birkett, D. J. Mechanism of action of paracetamol protective agents in mice in vivo. Biochem. Pharmacol. 33: 2995-3000; 1984. (Pubitemid 14044594)
28. Corcoran, G. B.; Todd, E. L.; Racz, W. J.; Hughes, H.; Smith, C. V.; Mitchell, J. R. Effects of N-acetylcysteine on the disposition and metabolism of acetaminophen in mice. J. Pharmacol. Exp. Ther. 232: 857-863; 1985. (Pubitemid 15135881)
29. Bondareva, A. A.; Capecchi, M. R.; Iverson, S. V.; Li, Y.; Lopez, N. I.; Lucas, O.; Merrill, G. F.; Prigge, J. R.; Siders, A. M.; Wakamiya, M.; Wallin, S. L.; Schmidt, E. E. Effects of thioredoxin reductase-1 deletion on embryogenesis and tran-scriptome. Free Radic. Biol. Med. 43: 911-923; 2007. (Pubitemid 47241204)
30. Prigge, J. R.; Eriksson, S.; Iverson, S. V.; Meade, T. A.; Capecchi, M. R.; Arnér, E. S. J.; Schmidt, E. E.; Hepatocyte, D. N. A. replication in growing liver requires either glutathione or a single allele of txnrd1. Free Radic. Biol. Med. 52: 803-810; 2012.
31. Rollins, M. F.; van der Heide, D. M.; Weisend, C. M.; Kundert, J. A.; Comstock, K. M.; Suvorova, E. S.; Capecchi, M. R.; Merrill, G. F.; Schmidt, E. E. Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration. J. Cell Sci. 123: 2402-2412; 2010.
32. Cheng, Q.; Antholine, W. E.; Myers, J. M.; Kalyanaraman, B.; Arner, E. S.; Myers, C. R. The selenium-independent inherent pro-oxidant NADPH oxidase activity of mammalian thioredoxin reductase and its selenium-dependent direct peroxidase activities. J. Biol. Chem. 285: 21708-21723; 2010.
33. Van Der Vies, J. Two methods for the determination of glycogen in liver. Biochem. J 57: 410-416; 1954.
34. Roesler, W. J.; Khandelwal, R. L. Diurnal variations in the activities of the glycogen metabolizing enzymes in mouse liver. Int. J. Biochem. 17 : 81-85; 1985. (Pubitemid 15108427)
35. McVerry, P.; Kim, K. H. Diurnal rhythm of rat liver glycogen synthetase. Biochem. Biophys. Res. Commun. 46: 1242-1246; 1972.
36. Suriawinata, A. A.; Thung, S. N. Liver pathology: an atlas and concise guide. New York: Demos Medical; 2011.
37. Foster, C. L. The demonstration of glycogen in liver cells fixed in osmium tetroxide. Q. J. Microsc. Sci. 101; 1960. 273-&.
38. Mitchell, J. R.; Jollow, D. J.; Potter, W. Z.; Gillette, J. R.; Brodie, B. B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187: 211-217; 1973.
39. Price, V. F.; Miller, M. G.; Jollow, D. J. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem. Pharmacol. 36: 427-433; 1987. (Pubitemid 17024162)
40. Anestål, K.; Prast-Nielsen, S.; Cenas, N.; Arnér, E. S. J. Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells. PLoS ONE 3:e1846; 2008.
41. Farber, J. L.; Gerson, R. J. Mechanisms of cell injury with hepatotoxic chemicals. Pharmacol. Rev. 36: 71S-75S; 1984. (Pubitemid 14093518)
42. Priyadarsiny, P.; Khattar, S. K.; Malik, R.; Udupa, V.; Seshaiah, A.; Rahman, S.; Shingatgeri, V. M.; Bora, R. S.; Saini, K. S. Differential gene expression analysis of a known hepatotoxin, N-acetyl-p-amino-phenol (APAP) as compared to its non-toxic analog, N-acetyl-m-amino-phenol (AMAP) in mouse liver. J. Toxicol. Sci. 33: 163-173; 2008. (Pubitemid 351872358)
43. Jeong, S. Y.; Lim, J. S.; Park, H. J.; Cho, J. W.; Rana, S. V.; Yoon, S. Effects of acetaminophen on hepatic gene expression in mice. Physiol. Chem. Phys. Med. NMR 38: 77-83; 2006. (Pubitemid 351547034)
44. Reilly, T. P.; Bourdi, M.; Brady, J. N.; Pise-Masison, C. A.; Radonovich, M. F.; George, J. W.; Pohl, L. R. Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem. Biophys. Res. Commun. 282: 321-328; 2001. (Pubitemid 32924382)
45. Griffith, O. W.; Meister, A. Origin and turnover of mitochondrial glutathione. Proc. Natl. Acad. Sci. USA 82: 4668-4672; 1985. (Pubitemid 16239624)
46. Rogers, L. K.; Tamura, T.; Rogers, B. J.; Welty, S. E.; Hansen, T. N.; Smith, C. V. Analyses of glutathione reductase hypomorphic mice indicate a genetic knockout. Toxicol. Sci. 82: 367-373; 2004. (Pubitemid 39600063)
47. Moffit, J. S.; Aleksunes, L. M.; Kardas, M. J.; Slitt, A. L.; Klaassen, C. D.; Manautou, J. E. Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen. Toxicology 230: 197-206; 2007. (Pubitemid 46109138)
48. Dong, H.; Haining, R. L.; Thummel, K. E.; Rettie, A. E.; Nelson, S. D. Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen. Drug Metab. Dispos. 28: 1397-1400; 2000.
49. Guo, G. L.; Moffit, J. S.; Nicol, C. J.; Ward, J. M.; Aleksunes, L. A.; Slitt, A. L.; Kliewer, S. A.; Manautou, J. E.; Gonzalez, F. J. Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol. Sci. 82: 374-380; 2004. (Pubitemid 39600064)
50. Thummel, K. E.; Lee, C. A.; Kunze, K. L.; Nelson, S. D.; Slattery, J. T. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem. Pharmacol. 45: 1563-1569; 1993. (Pubitemid 23130300)
51. Agarwal, R.; MacMillan-Crow, L. A.; Rafferty, T. M.; Saba, H.; Roberts, D. W.; Fifer, E. K.; James, L. P.; Hinson, J. A. Acetaminophen-induced hepatotoxicity in mice occurs with inhibition of activity and nitration of mitochondrial manganese superoxide dismutase. J. Pharmacol. Exp. Ther. 337: 110 -116; 2011.
52. Prast-Nielsen, S.; Cebula, M.; Pader, I.; Arnér, E. S. J. Noble metal targeting of thioredoxin reductase - covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin. Free Radic. Biol. Med.; 2010.
53. James, L. P.; McCullough, S. S.; Lamps, L. W.; Hinson, J. A. Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. Toxicol. Sci. 75: 458-467; 2003. (Pubitemid 37220292)